The Department of Medicine is thrilled to announce the promotion of Agnieszka Bialkowska, Ph.D., in the Division Gastroenterology and Hepatology, to Associate Professor of Medicine with tenure.
Dr. Agnieszka Bialkowska received her PhD degree in Microbiology in 2003 from the Institute of Biochemistry and Biophysics at the Polish Academy of Sciences in Warsaw. She furthered her training in gene therapy and cancer biology during her postdoctoral studies at Louisiana Health Science Center in New Orleans and Emory University in Atlanta, respectively.
In 2011 she joined the Division of Gastroenterology and Hepatology at Stony Brook University. Dr. Bialkowska studies are focused on two major projects: the first project is focused on understanding the mechanisms of intestinal inflammation and carcinogenesis. Specifically, she is interested in the role of the transcription factor Krüppel-Like Factor 5 (KLF5) as a key regulator of epithelial homeostasis in the gastrointestinal tract. The second project is focused on understanding mechanisms regulating the development and progression of pancreatic diseases.
Dr. Bialkowska is interested in the interaction between acinar cells, immune cells, and stellate cells and how this cross-talk shapes the response of the pancreas to the injury. Her research involves the understanding of the role that the pancreatic environment has on the development and progression of pancreatic diseases.
Her work in this area promises to allow for the development of therapeutics for pancreatic diseases. Her studies are supported by the United States National Institutes of Health and Pilot Project grants from Department of Medicine, Stony Brook University.
Dr. Bialkowska teaches, mentors, and supervises the laboratory efforts of high school, undergraduate, graduate, and medical students, postdoctoral associates, and research assistants.
She is a member of the School of Medicine Faculty Senate at Stony Brook School of Medicine, the Cancer Center’s Oncogenic Drivers and Mechanisms of Carcinogenesis Program, and Institute of Chemical Biology & Drug Discovery (ICB&DD) at Stony Brook University. In addition, she is involved in grant application review process at NIH, European Research Council, and Medical Research Council at UK Research and Innovation.
The Department of Medicine values Dr. Bialkowska's consistent dedication. We recognize the important contributions that she has made, and wish her the best in her future research endeavors. Please join us in congratulating Dr. Bialkowska on this very distinguished and well-deserved honor.
